(Q33915484)

30 July 2017

1 reference

title

How accelerated atherosclerosis in SLE has changed our management of the disorder (English)

1 reference

30 July 2017

1 reference

D S Hallegua

1

1 reference

30 July 2017

D J Wallace

series ordinal

2

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

228-231

1 reference

A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

SLE mortality in an oriental population

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

Long-term treatment of lupus nephritis with cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

Predictors of change in insulin sensitivity during glucocorticoid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

The significance of arterial hypertension at the onset of clinical lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

HLA-B associations of HLA-B27 negative ankylosing spondylitis: Comment on the article by Yamaguchi et al

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120300678828181

10.1191/096120300678828181

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference